학술논문
Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
Document Type
Article
Author
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, March 2022, 10(3):247-254)
Subject
Language
English
ISSN
22132619
22132600
22132600